Detalhe da pesquisa
1.
Alectinib-induced hemolytic anemia.
J Oncol Pharm Pract
; 29(5): 1251-1254, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36604860
2.
A deep dive into CDK4/6 inhibitors: Evaluating real world toxicities and treatment paradigms in the elderly population.
J Oncol Pharm Pract
; 29(1): 14-21, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34665067
3.
Inpatient utilization of immune checkpoint inhibitors and clinical outcomes.
J Oncol Pharm Pract
; 29(6): 1392-1397, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36131556
4.
A contemporary review of rearranged during transfection-selective inhibitors.
J Oncol Pharm Pract
; 28(1): 175-184, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590525
5.
A real world analysis of first line treatment of advanced EGFR mutated non-small cell lung cancer: A multi-center, retrospective study.
J Oncol Pharm Pract
; 28(5): 1140-1151, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34120514
6.
Lorlatinib induced proteinuria: A case report.
J Oncol Pharm Pract
; 27(4): 1037-1039, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32996364
7.
A retrospective analysis of tumor lysis syndrome management in a quaternary care hospital.
J Oncol Pharm Pract
; 26(2): 338-344, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31088218
8.
Bevacizumab-induced dysphonia: A case report with brief review of literature.
J Oncol Pharm Pract
; 26(4): 1032-1036, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31771464
9.
Pemetrexed-induced severe rhabdomyolysis in lung cancer: A case report.
J Oncol Pharm Pract
; 25(8): 2007-2009, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30501380
10.
Penetrating the evidence of EGFR and ALK tyrosine kinase inhibitors for non-small cell lung cancer brain metastases.
J Oncol Pharm Pract
; 25(3): 623-637, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30176786
11.
A review of a novel, Bruton's tyrosine kinase inhibitor, ibrutinib.
J Oncol Pharm Pract
; 22(1): 92-104, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25425007
12.
Profile of Capmatinib for the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Patient Selection and Perspectives.
Cancer Manag Res
; 15: 1233-1243, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37941971
13.
Safety and Efficacy of Immune Checkpoint Inhibitors in Cancer Patients and Preexisting Autoimmune Disease: A Systematic Review and Meta-Analysis in Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 24(7): 598-612, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37328320
14.
A Real World Perspective of PARP Inhibitor Use in Gynecological Cancer Patients.
J Pharm Pract
; 36(5): 1134-1141, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35439094
15.
A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer.
Clin Med Insights Oncol
; 17: 11795549231152073, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36744171
16.
Characteristics of Patients With Second Primary Lung Cancer Following Breast Cancer: A Retrospective Descriptive Study.
Clin Lung Cancer
; 24(6): e198-e204, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37268494
17.
Osimertinib in EGFR-Mutated Lung Cancer: A Review of the Existing and Emerging Clinical Data.
Onco Targets Ther
; 14: 4579-4597, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34471361
18.
Impact of Tyrosine Kinase Inhibitor Starting Dose on Outcomes in Patients With Non-Small Cell Lung Cancer.
J Pharm Pract
; 34(1): 11-16, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31167592
19.
Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer.
SAGE Open Med
; 9: 20503121211017757, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34104436
20.
Clinical efficacy with dabrafenib and trametinib in a T599_V600insT poorly differentiated metastatic thyroid carcinoma.
BMJ Case Rep
; 14(8)2021 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34413035